<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Country</title>
	<atom:link href="http://www.tapanray.in/tag/country/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Covid 2.0 Rampages India As Top Echelon Policy Makers Ignore Science</title>
		<link>http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science</link>
		<comments>http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/#comments</comments>
		<pubDate>Mon, 26 Apr 2021 00:00:54 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[appropriate]]></category>
		<category><![CDATA[beds]]></category>
		<category><![CDATA[behavior]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[Court]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[Covid 2.0]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Delhi]]></category>
		<category><![CDATA[dilemmas]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[foreign]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[Media]]></category>
		<category><![CDATA[misgivings]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[overwhelmed]]></category>
		<category><![CDATA[Oxygen]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[rampage]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[remdesivir]]></category>
		<category><![CDATA[shortage]]></category>
		<category><![CDATA[side-effects]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Supreme]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Vaccine]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10482</guid>
		<description><![CDATA[‘India is in the endgame of COVID,’ announced the union health minister of India, just in the last month – March 08, 2021. Although, it was then clearly known to medical fraternity that today’s Covid vaccines won’t be magic bullets against rapidly &#8230; <a href="http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India Being World’s Third largest Covid Vaccine Maker: Will All Indians Benefit?</title>
		<link>http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit</link>
		<comments>http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/#comments</comments>
		<pubDate>Mon, 02 Nov 2020 00:00:30 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[all third]]></category>
		<category><![CDATA[ambiguity]]></category>
		<category><![CDATA[assembly]]></category>
		<category><![CDATA[Availability]]></category>
		<category><![CDATA[benefit]]></category>
		<category><![CDATA[Bihar]]></category>
		<category><![CDATA[cold-chain]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[countrywide]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[distribution]]></category>
		<category><![CDATA[election]]></category>
		<category><![CDATA[equitable]]></category>
		<category><![CDATA[Free]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indians]]></category>
		<category><![CDATA[infection]]></category>
		<category><![CDATA[largest]]></category>
		<category><![CDATA[logistics]]></category>
		<category><![CDATA[maker]]></category>
		<category><![CDATA[manufacturer]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[Nationalism]]></category>
		<category><![CDATA[oxfam]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[SII]]></category>
		<category><![CDATA[supply-chain]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[uninterrupted]]></category>
		<category><![CDATA[vaccination]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[virus]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10311</guid>
		<description><![CDATA[Apprehensions on the time of availability notwithstanding, equitable access to Covid vaccines for all, remain the best hope to leash the deadly virus, as the pandemic overwhelms the world. According to the World Health Organization (WHO) ‘Coronavirus Update 37’ of October 06, &#8230; <a href="http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acid Test For Excellence in Crisis Leadership</title>
		<link>http://www.tapanray.in/acid-test-for-excellence-in-crisis-leadership/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=acid-test-for-excellence-in-crisis-leadership</link>
		<comments>http://www.tapanray.in/acid-test-for-excellence-in-crisis-leadership/#comments</comments>
		<pubDate>Mon, 13 Apr 2020 00:07:29 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[21 day]]></category>
		<category><![CDATA[Acid]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[Covid19]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Juty]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[leadership]]></category>
		<category><![CDATA[lockdown]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[Mask]]></category>
		<category><![CDATA[out]]></category>
		<category><![CDATA[Outbreak]]></category>
		<category><![CDATA[PPE]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Social]]></category>
		<category><![CDATA[society]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[test]]></category>
		<category><![CDATA[turnaround]]></category>
		<category><![CDATA[United Staes]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9986</guid>
		<description><![CDATA[On April 12, 2020 – in the morning of the day 19 of the national lockdown, India’s total number of Coronavirus positive cases reached 8,504 with 289 deaths. The country&#8217;s trajectory is reportedly  steeper than most Asian peers, such as Singapore, Japan, and Indonesia. &#8230; <a href="http://www.tapanray.in/acid-test-for-excellence-in-crisis-leadership/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/acid-test-for-excellence-in-crisis-leadership/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Playing Hardball, Riding the Horse of ‘Innovation’</title>
		<link>http://www.tapanray.in/playing-hardball-riding-the-horse-of-innovation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=playing-hardball-riding-the-horse-of-innovation</link>
		<comments>http://www.tapanray.in/playing-hardball-riding-the-horse-of-innovation/#comments</comments>
		<pubDate>Mon, 31 Mar 2014 00:00:45 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[3d]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Bad]]></category>
		<category><![CDATA[beggars]]></category>
		<category><![CDATA[Ben]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[Doha]]></category>
		<category><![CDATA[foreign]]></category>
		<category><![CDATA[Goldacre]]></category>
		<category><![CDATA[hardball]]></category>
		<category><![CDATA[horse]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Law]]></category>
		<category><![CDATA[me-again]]></category>
		<category><![CDATA[me-too]]></category>
		<category><![CDATA[NME]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[playing]]></category>
		<category><![CDATA[Priority]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[ride]]></category>
		<category><![CDATA[riding]]></category>
		<category><![CDATA[section]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[wishes]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5157</guid>
		<description><![CDATA[Media reports are now abuzz with various stories related to intense pressure being created by Big Pharma on the United States Government to declare India as a ‘Priority Foreign Country’ for initiating ‘Trade Sanctions’. As we know, ‘Priority Foreign Country’ &#8230; <a href="http://www.tapanray.in/playing-hardball-riding-the-horse-of-innovation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/playing-hardball-riding-the-horse-of-innovation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India &#8211; Young Today, Old Tomorrow: Emerging Issues of Aging, Health and Socioeconomic Profile of the Country</title>
		<link>http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country</link>
		<comments>http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/#comments</comments>
		<pubDate>Sun, 29 Apr 2012 01:30:13 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aging]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[emerging]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Old]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Profile]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[Tomorrow]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[Young]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=100</guid>
		<description><![CDATA[‘World Health Day’ is celebrated every year on April 7, the day ‘World Health Organization (WHO)’ was founded in 1948. Each year, on this day, people from all walks of life across the globe are invited by WHO to focus &#8230; <a href="http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Should India follow the US way to regulate all types of lobbying in the country?</title>
		<link>http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country</link>
		<comments>http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/#comments</comments>
		<pubDate>Mon, 31 Oct 2011 00:00:55 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[follow]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[lobbying]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[radia]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulate]]></category>
		<category><![CDATA[scam]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[types]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=181</guid>
		<description><![CDATA[Currently, India is one of the fastest-growing economies of the world along with China. Even during the recent global financial meltdown process both India and China could register a very impressive average GDP growth of around 7% consistently during the &#8230; <a href="http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Access to affordable healthcare to 65% of Indian population still remains a key issue even after six decades of independence of the country.</title>
		<link>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country</link>
		<comments>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/#comments</comments>
		<pubDate>Mon, 12 Apr 2010 01:30:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[65%]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[after]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[decades]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[independence]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[key]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[remains]]></category>
		<category><![CDATA[six]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=442</guid>
		<description><![CDATA[Despite so much of stringent government control, debate and activism on the affordability of modern medicines in India, on the one hand, and the success of the government to make medicines available in the country at a price, which is &#8230; <a href="http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Patent office (IPO) asks for details of ‘working of patents’ in India – does it herald the beginning of a new chapter in the IPR regime of the country or it could trigger another raging debate</title>
		<link>http://www.tapanray.in/indian-patent-office-ipo-asks-for-details-of-working-of-patents-in-india-does-it-herald-the-beginning-of-a-new-chapter-in-the-ipr-regime-of-the-country-or-it-could-trigge/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-patent-office-ipo-asks-for-details-of-working-of-patents-in-india-does-it-herald-the-beginning-of-a-new-chapter-in-the-ipr-regime-of-the-country-or-it-could-trigge</link>
		<comments>http://www.tapanray.in/indian-patent-office-ipo-asks-for-details-of-working-of-patents-in-india-does-it-herald-the-beginning-of-a-new-chapter-in-the-ipr-regime-of-the-country-or-it-could-trigge/#comments</comments>
		<pubDate>Mon, 25 Jan 2010 01:30:27 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[another]]></category>
		<category><![CDATA[asks]]></category>
		<category><![CDATA[beginning]]></category>
		<category><![CDATA[chapter]]></category>
		<category><![CDATA[controller]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[CSPDTM]]></category>
		<category><![CDATA[debate]]></category>
		<category><![CDATA[details]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[herald]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[IPO]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Office]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[raging]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regime]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[trigger]]></category>
		<category><![CDATA[working]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=479</guid>
		<description><![CDATA[A Public Notice dated 24/12/2009 issued by the Controller General of Patents, Design &#38; Trade Marks, directing all Patentees and Licensees to furnish information in Form No.27 on &#8216;Working of Patents&#8217; as prescribed under Section 146 of the Patents Act &#8230; <a href="http://www.tapanray.in/indian-patent-office-ipo-asks-for-details-of-working-of-patents-in-india-does-it-herald-the-beginning-of-a-new-chapter-in-the-ipr-regime-of-the-country-or-it-could-trigge/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-patent-office-ipo-asks-for-details-of-working-of-patents-in-india-does-it-herald-the-beginning-of-a-new-chapter-in-the-ipr-regime-of-the-country-or-it-could-trigge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are common patients in India just as the pawns of the game of chess or the victims of circumstances or both, in the socio-economic milieu of the country?</title>
		<link>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country</link>
		<comments>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/#comments</comments>
		<pubDate>Mon, 18 Jan 2010 00:30:38 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[as]]></category>
		<category><![CDATA[both]]></category>
		<category><![CDATA[centric]]></category>
		<category><![CDATA[chess]]></category>
		<category><![CDATA[circumstances]]></category>
		<category><![CDATA[common]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[just]]></category>
		<category><![CDATA[milieu]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[pawns]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[victims]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=482</guid>
		<description><![CDATA[“Public healthcare in India has the power to deliver improved health outcomes, as demonstrated by a growing number of national and international examples. However, supportive policies need to be put in place in order to change traditional determinants of health,”said &#8230; <a href="http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The relevance of the Indian version of the Bayh-Dole Act – the country needs all stakeholders’ open debate on the proposed bill.</title>
		<link>http://www.tapanray.in/the-relevance-of-the-indian-version-of-the-bayh-dole-act-the-country-needs-all-stakeholders-open-debate-on-the-proposed-bill/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-relevance-of-the-indian-version-of-the-bayh-dole-act-the-country-needs-all-stakeholders-open-debate-on-the-proposed-bill</link>
		<comments>http://www.tapanray.in/the-relevance-of-the-indian-version-of-the-bayh-dole-act-the-country-needs-all-stakeholders-open-debate-on-the-proposed-bill/#comments</comments>
		<pubDate>Mon, 19 Oct 2009 01:30:35 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[academia]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[Bayh]]></category>
		<category><![CDATA[Bayh-Dole]]></category>
		<category><![CDATA[Bill]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[debate]]></category>
		<category><![CDATA[Dole]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Open]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[proposed]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Relevance]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[version]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=751</guid>
		<description><![CDATA[The Bayh-Dole Act is an American legislation, which was originally sponsored by two US senators named Birch Bayh and Bob Dole. This Act deals with Intellectual Property (IP) arising out of US government funding. Bayh-Dole Act is also known as &#8230; <a href="http://www.tapanray.in/the-relevance-of-the-indian-version-of-the-bayh-dole-act-the-country-needs-all-stakeholders-open-debate-on-the-proposed-bill/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-relevance-of-the-indian-version-of-the-bayh-dole-act-the-country-needs-all-stakeholders-open-debate-on-the-proposed-bill/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
